View in EDS

Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study.

Saved in:
Bibliographic Details
Title: Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study.
Authors: Singer SR; Public Health Services, Israel Ministry of Health, Jerusalem, Israel.; Hadassah Braun School of Public Health, Faculty of Medicine, Hebrew University, Jerusalem, Israel., Angulo FJ; Pfizer Inc., Collegeville, PA, USA., Swerdlow DL; Pfizer Inc., Collegeville, PA, USA., McLaughlin JM; Pfizer Inc., Collegeville, PA, USA., Hazan I; Ministry of Defense, Tel Aviv, Israel., Ginish N; Ministry of Defense, Tel Aviv, Israel., Anis E; Public Health Services, Israel Ministry of Health, Jerusalem, Israel.; Hadassah Braun School of Public Health, Faculty of Medicine, Hebrew University, Jerusalem, Israel., Mendelson E; Central Virology Laboratory, Sheba Medical Center, Ramat Gan, Israel.; School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Mor O; Central Virology Laboratory, Sheba Medical Center, Ramat Gan, Israel.; School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Zuckerman NS; Central Virology Laboratory, Sheba Medical Center, Ramat Gan, Israel.; School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Erster O; Central Virology Laboratory, Sheba Medical Center, Ramat Gan, Israel.; School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Southern J; Pfizer Inc., Collegeville, PA, USA., Pan K; Pfizer Inc., Collegeville, PA, USA., Mircus G; Pfizer Pharmaceuticals Israel Ltd, Herzliya, Israel., Lipsitch M; Harvard University, Boston, MA, USA., Haas EJ; Public Health Services, Israel Ministry of Health, Jerusalem, Israel.; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel., Jodar L; Pfizer Inc., Collegeville, PA, USA., Levy Y; Israel Ministry of Health, Jerusalem, Israel., Alroy-Preis S; Public Health Services, Israel Ministry of Health, Jerusalem, Israel.
Source: EClinicalMedicine [EClinicalMedicine] 2021 Dec; Vol. 42, pp. 101190. Date of Electronic Publication: 2021 Nov 29.
Publication Type: Journal Article
Journal Info: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34870134
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Singer+SR%22">Singer SR</searchLink>; Public Health Services, Israel Ministry of Health, Jerusalem, Israel.; Hadassah Braun School of Public Health, Faculty of Medicine, Hebrew University, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Angulo+FJ%22">Angulo FJ</searchLink>; Pfizer Inc., Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Swerdlow+DL%22">Swerdlow DL</searchLink>; Pfizer Inc., Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22McLaughlin+JM%22">McLaughlin JM</searchLink>; Pfizer Inc., Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Hazan+I%22">Hazan I</searchLink>; Ministry of Defense, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Ginish+N%22">Ginish N</searchLink>; Ministry of Defense, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Anis+E%22">Anis E</searchLink>; Public Health Services, Israel Ministry of Health, Jerusalem, Israel.; Hadassah Braun School of Public Health, Faculty of Medicine, Hebrew University, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Mendelson+E%22">Mendelson E</searchLink>; Central Virology Laboratory, Sheba Medical Center, Ramat Gan, Israel.; School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Mor+O%22">Mor O</searchLink>; Central Virology Laboratory, Sheba Medical Center, Ramat Gan, Israel.; School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Zuckerman+NS%22">Zuckerman NS</searchLink>; Central Virology Laboratory, Sheba Medical Center, Ramat Gan, Israel.; School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Erster+O%22">Erster O</searchLink>; Central Virology Laboratory, Sheba Medical Center, Ramat Gan, Israel.; School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Southern+J%22">Southern J</searchLink>; Pfizer Inc., Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Pan+K%22">Pan K</searchLink>; Pfizer Inc., Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Mircus+G%22">Mircus G</searchLink>; Pfizer Pharmaceuticals Israel Ltd, Herzliya, Israel.<br /><searchLink fieldCode="AU" term="%22Lipsitch+M%22">Lipsitch M</searchLink>; Harvard University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Haas+EJ%22">Haas EJ</searchLink>; Public Health Services, Israel Ministry of Health, Jerusalem, Israel.; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Jodar+L%22">Jodar L</searchLink>; Pfizer Inc., Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Levy+Y%22">Levy Y</searchLink>; Israel Ministry of Health, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Alroy-Preis+S%22">Alroy-Preis S</searchLink>; Public Health Services, Israel Ministry of Health, Jerusalem, Israel.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101733727%22">EClinicalMedicine</searchLink> [EClinicalMedicine] 2021 Dec; Vol. 42, pp. 101190. <i>Date of Electronic Publication: </i>2021 Nov 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22The+Lancet%22">The Lancet </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101733727 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-5370 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225895370%22">25895370 </searchLink><i>NLM ISO Abbreviation: </i>EClinicalMedicine <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34870134
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.eclinm.2021.101190
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 101190
    Titles:
      – TitleFull: Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Singer SR
      – PersonEntity:
          Name:
            NameFull: Angulo FJ
      – PersonEntity:
          Name:
            NameFull: Swerdlow DL
      – PersonEntity:
          Name:
            NameFull: McLaughlin JM
      – PersonEntity:
          Name:
            NameFull: Hazan I
      – PersonEntity:
          Name:
            NameFull: Ginish N
      – PersonEntity:
          Name:
            NameFull: Anis E
      – PersonEntity:
          Name:
            NameFull: Mendelson E
      – PersonEntity:
          Name:
            NameFull: Mor O
      – PersonEntity:
          Name:
            NameFull: Zuckerman NS
      – PersonEntity:
          Name:
            NameFull: Erster O
      – PersonEntity:
          Name:
            NameFull: Southern J
      – PersonEntity:
          Name:
            NameFull: Pan K
      – PersonEntity:
          Name:
            NameFull: Mircus G
      – PersonEntity:
          Name:
            NameFull: Lipsitch M
      – PersonEntity:
          Name:
            NameFull: Haas EJ
      – PersonEntity:
          Name:
            NameFull: Jodar L
      – PersonEntity:
          Name:
            NameFull: Levy Y
      – PersonEntity:
          Name:
            NameFull: Alroy-Preis S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2021 Dec
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2589-5370
          Numbering:
            – Type: volume
              Value: 42
          Titles:
            – TitleFull: EClinicalMedicine
              Type: main
ResultId 1